483 Amphastar Pharmaceuticals Jun 2012

483 Amphastar Pharmaceuticals Jun 2012

John Gonzalez FDA, Carla Lundi FDA$119.00 - Available Now

FDA investigators audited the Amphastar Pharmaceuticals - Rancho Cucamonga, CA, United States facility and issued inspectional observations (via FDA 483) on 28 Jun 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jun 2012
  • Location: Rancho Cucamonga, United States
  • FEI: 3002936358
Add To Cart